Thymalfasin Research
Liu 2020 — Thymosin Alpha-1 in COVID-19 Wuhan
Clin Infect Dis·November 1, 2020
Yueping Liu, Yue Pan, Zhenhong Hu, Ming Wu, Chenhui Wang, et al., Yongwen Chen
Summary
Tα1 reduced mortality in severe COVID-19 patients through restoration of lymphocytopenia and reversion of exhausted T cells.
Study Details
Study Design
Retrospective cohort
Indication
COVID-19 severe cases
Intervention
Thymosin alpha-1
Species
Human
Sample Size
76 subjects
Risk of Bias Assessment
Retrospective; single center
Tags
SourceCOVID 19ThymalfasinRetrospectiveWuhan